Skip to main content
. 2022 Mar 15;13:831092. doi: 10.3389/fpsyt.2022.831092

Table 7.

Change in PHQ-9, GAD-7, and HERO scores by lifetime psychedelic usage.

PHQ-9 GAD-7 HERO
Number of uses N Mean d Mean d Mean d
1-5 610 −5.52 0.90 −5.23 0.95 9.20 0.90
6-10 544 −5.88 1.05 −5.55 1.07 9.92 0.99
11-15 273 −6.13 1.05 −5.80 1.11 12.08 1.19
16-20 214 −5.86 0.98 −5.57 1.02 12.63 1.20
21-25 113 −6.62 1.05 −6.17 1.19 13.15 1.14
26-30 148 −6.98 1.16 −6.76 1.32 12.58 1.28
31-35 38 −7.74 1.36 −6.76 1.30 13.74 1.45
36-40 73 −6.82 1.17 −6.07 1.04 12.20 1.16
41-45 9 −9.78 1.74 −7.67 1.87 10.78 1.16
46-50 96 −6.05 0.93 −5.90 0.90 13.33 1.04
>50 392 −6.26 1.06 −6.13 1.09 13.43 1.25

PHQ-9, Patient Health Questionnaire.

GAD-7, Generalized Anxiety Disorder Scale.

HERO, HERO Wellness Scale.

d, Cohen's d.